Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.66 Million USD | 6.27% |
| 2022 | 4.39 Million USD | 149.06% |
| 2021 | 1.76 Million USD | 428.93% |
| 2020 | 333.48 Thousand USD | 133.34% |
| 2019 | -1 Million USD | -234.17% |
| 2018 | -299.3 Thousand USD | -287.84% |
| 2017 | 159.34 Thousand USD | 214.09% |
| 2016 | -139.66 Thousand USD | -104.88% |
| 2015 | 2.86 Million USD | 32.48% |
| 2014 | 2.15 Million USD | -54.1% |
| 2013 | 4.7 Million USD | 4.79% |
| 2012 | 4.49 Million USD | 336.0% |
| 2011 | 1.03 Million USD | 865.37% |
| 2010 | 106.69 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2001 | 970 Thousand USD | -59.75% |
| 2000 | 2.41 Million USD | -17.47% |
| 1999 | 2.92 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.37 Million USD | 2.94% |
| 2024 Q1 | 1.18 Million USD | 17.31% |
| 2023 Q2 | 1.46 Million USD | 23.16% |
| 2023 Q1 | 1.18 Million USD | 25.98% |
| 2023 FY | 4.66 Million USD | 6.27% |
| 2023 Q4 | 1 Million USD | -19.2% |
| 2023 Q3 | 1.24 Million USD | -14.65% |
| 2022 Q3 | 1.31 Million USD | 27.39% |
| 2022 FY | 4.39 Million USD | 149.06% |
| 2022 Q4 | 941.03 Thousand USD | -28.18% |
| 2022 Q2 | 1.02 Million USD | 10.2% |
| 2022 Q1 | 933.28 Thousand USD | 43.41% |
| 2021 Q1 | 89.29 Thousand USD | 31.16% |
| 2021 Q4 | 650.76 Thousand USD | -16.41% |
| 2021 FY | 1.76 Million USD | 428.93% |
| 2021 Q3 | 778.55 Thousand USD | 718.28% |
| 2021 Q2 | 95.14 Thousand USD | 6.55% |
| 2020 FY | 333.48 Thousand USD | 133.34% |
| 2020 Q4 | 68.07 Thousand USD | -22.93% |
| 2020 Q3 | 88.32 Thousand USD | 9.32% |
| 2020 Q2 | 80.8 Thousand USD | -2.11% |
| 2020 Q1 | 82.54 Thousand USD | 156.91% |
| 2019 Q1 | -488.05 Thousand USD | -55.46% |
| 2019 Q4 | -145.03 Thousand USD | 49.03% |
| 2019 FY | -1 Million USD | -234.17% |
| 2019 Q2 | -111.17 Thousand USD | 77.22% |
| 2019 Q3 | -284.57 Thousand USD | -155.97% |
| 2018 Q3 | -199.37 Thousand USD | -40.81% |
| 2018 Q1 | -71.85 Thousand USD | 88.6% |
| 2018 Q2 | -141.58 Thousand USD | -97.05% |
| 2018 Q4 | -313.94 Thousand USD | -57.47% |
| 2018 FY | -299.3 Thousand USD | -287.84% |
| 2017 Q4 | -630.12 Thousand USD | -240.83% |
| 2017 FY | 159.34 Thousand USD | 214.09% |
| 2017 Q3 | 447.43 Thousand USD | 95.58% |
| 2017 Q2 | 228.76 Thousand USD | 101.98% |
| 2017 Q1 | 113.26 Thousand USD | 103.84% |
| 2016 Q2 | 918.66 Thousand USD | 22.74% |
| 2016 FY | -139.66 Thousand USD | -104.88% |
| 2016 Q4 | -2.95 Million USD | -403.91% |
| 2016 Q1 | 748.44 Thousand USD | 13.15% |
| 2016 Q3 | 971.42 Thousand USD | 5.74% |
| 2015 FY | 2.86 Million USD | 32.48% |
| 2015 Q2 | 857.29 Thousand USD | 44.82% |
| 2015 Q3 | 764.59 Thousand USD | -10.81% |
| 2015 Q4 | 661.46 Thousand USD | -13.49% |
| 2015 Q1 | 591.95 Thousand USD | 9823.34% |
| 2014 Q2 | 1.28 Million USD | 50.69% |
| 2014 FY | 2.15 Million USD | -54.1% |
| 2014 Q4 | -6088.00 USD | 99.99% |
| 2014 Q3 | -81.64 Million USD | -6464.97% |
| 2014 Q1 | 851.21 Thousand USD | -14.29% |
| 2013 Q4 | 993.14 Thousand USD | -27.66% |
| 2013 Q3 | 1.37 Million USD | 15.5% |
| 2013 FY | 4.7 Million USD | 4.79% |
| 2013 Q1 | 1.15 Million USD | -12.27% |
| 2013 Q2 | 1.18 Million USD | 3.26% |
| 2012 Q3 | 1.06 Million USD | -3.08% |
| 2012 FY | 4.49 Million USD | 336.0% |
| 2012 Q4 | 1.31 Million USD | 22.76% |
| 2012 Q1 | 1 Million USD | 92.43% |
| 2012 Q2 | 1.1 Million USD | 9.6% |
| 2011 Q2 | 121.67 Thousand USD | 29.66% |
| 2011 Q4 | 522.89 Thousand USD | 79.31% |
| 2011 Q3 | 291.6 Thousand USD | 139.65% |
| 2011 Q1 | 93.84 Thousand USD | -40.48% |
| 2011 FY | 1.03 Million USD | 865.37% |
| 2010 FY | 106.69 Thousand USD | 0.0% |
| 2010 Q4 | 157.68 Thousand USD | 406.34% |
| 2010 Q3 | 31.14 Thousand USD | 1205.16% |
| 2010 Q2 | 2386.00 USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2001 Q3 | 390 Thousand USD | 18.18% |
| 2001 Q4 | 20 Thousand USD | -94.87% |
| 2001 FY | 970 Thousand USD | -59.75% |
| 2001 Q2 | 330 Thousand USD | 43.48% |
| 2001 Q1 | 230 Thousand USD | -74.44% |
| 2000 FY | 2.41 Million USD | -17.47% |
| 2000 Q2 | 430 Thousand USD | -6.52% |
| 2000 Q3 | 620 Thousand USD | 44.19% |
| 2000 Q4 | 900 Thousand USD | 45.16% |
| 2000 Q1 | 460 Thousand USD | 0.0% |
| 1999 FY | 2.92 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | 50.319% |
| Arem Pacific Corporation | 239.16 Thousand USD | -1852.165% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -555.437% |
| BioCorRx Inc. | 53.17 Thousand USD | -8680.301% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -371.658% |
| Banyan Corp. | 5 Million USD | 6.692% |
| Clearday, Inc. | -6.84 Million USD | 168.162% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -43.909% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -425263.927% |
| Empower Clinics Inc. | 1.96 Million USD | -137.235% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 38381.707% |
| Selectis Health, Inc. | 5.4 Million USD | 13.654% |
| HealthLynked Corp. | 2.34 Million USD | -98.779% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | 31.185% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -866.531% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 96.751% |
| MedSmart Group Inc. | -19.03 Thousand USD | 24623.779% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -6273.317% |
| Nova Leap Health Corp. | 9.76 Million USD | 52.205% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1227.645% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 55.542% |
| Raffles Medical Group Ltd | 239.4 Million USD | 98.05% |
| Ryman Healthcare Limited | 260.65 Million USD | 98.209% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 485.453% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 7726.7% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 23444.185% |
| Veltex Corporation | 694.58 Thousand USD | -572.176% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -1487.408% |